GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD)

CUSIP: M47238122

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / SHS NEW
Total 13F shares
691,438
Share change
+547,901
Total reported value
$429,211
Price per share
$0.62
Number of holders
16
Value change
+$74,839
Number of buys
10
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP M47238122?
CUSIP M47238122 identifies GLMD - GALMED PHARMACEUTICALS LTD - SHS NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) as of Q3 2023

As of 30 Sep 2023, GALMED PHARMACEUTICALS LTD - SHS NEW (GLMD) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 691,438 shares. The largest 10 holders included Walleye Capital LLC, CVI Holdings, LLC, TWO SIGMA ADVISERS, LP, CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, Virtu Financial LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, and TSFG, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.